Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169975 · ClinicalTrials.gov registry record
Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 137
- Enrollment target
NCT00169975: Completed study, sponsored by Mayo Clinic.
NCT00169975 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 137 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00169975 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 137 participants
- Enrollment target
Study Summary
A magnetocardiograph (MCG) is a device capable of recording of magnetic fields arising from the electrical activity of the heart with traces similar to an electrocardiogram (ECG). This system was developed as a noninvasive, non-contact diagnostics of obstructive coronary artery disease (CAD), and especially of lack of oxygen in the heart as in a heart attack. The overall objective of this study is to demonstrate the efficacy of this MCG device for the detection and diagnosis of lack of oxygen of the heart in patients with chest pain.
Interventions
- DEVICE Magnetocardiograph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2004-08 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00169975
The ClinicalTrials.gov registry entry for NCT00169975 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetocardiograph is the first listed.
NCT00169975 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00169975 about?
NCT00169975 is a clinical study titled "Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.". A magnetocardiograph (MCG) is a device capable of recording of magnetic fields arising from the electrical activity of the heart with traces similar to an electrocardiogram (ECG). This system was developed as a noninvasive, non-contact diagnostics of obstructive coronary artery disease (CAD), and es...
What is the current status of trial NCT00169975?
This trial is currently completed. The enrollment target is 137 participants. The study started on 2004-08. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00169975?
The interventions under investigation include: Magnetocardiograph (DEVICE).
Who is sponsoring clinical trial NCT00169975?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.